세포치료용 배지 시장 : 제품 유형별, 세포치료 유형별, 사업 규모별, 최종사용자 유형별, 주요 지역별 : 업계 동향과 세계 예측(-2035년)
Cell Therapy Media Market by Type of Product, Type of Cell Therapy, Scale of Operation, Type of End User and Key Geographical Regions : Industry Trends and Global Forecasts, Till 2035
상품코드:1616884
리서치사:Roots Analysis
발행일:2024년 12월
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 세포치료용 배지 시장 규모는 2035년까지의 예측 기간 중 12%의 CAGR로 확대하며, 현재 11억 달러에서 2035년까지 44억 달러로 성장할 것으로 예측됩니다.
종양성 질환, 희귀질환, 만성질환 치료에서 FDA 승인을 받은 세포치료제의 수많은 발전과 입증된 성공에 힘입어, 이 치료법은 헬스케어 업계에서 큰 주목을 받고 있으며, 2019년 이후 1,000건 이상의 세포치료제 관련 임상시험이 시작되었습니다. 시작되었습니다는 점은 주목할 만합니다. 또한 35개 이상의 세포치료제와 유전자치료제가 다양한 지역에서 상용화되고 있습니다. 최근 승인된 세포치료제 중 주목할 만한 사례로는 Breyanzi(R), Carvykti(TM), Abecma(R) 등이 있습니다.
최근 수년간 세포치료제 생산에 대한 규제가 강화되고 있습니다. 세포치료제 소모품 생산과 관련된 규제 문제를 해결하기 위해 세포치료제 개발자의 90% 이상이 배양배지, 키트, 시약, 세포외 매트릭스를 고품질의 원료를 제공하는 데 필요한 전문성을 갖춘 공급업체에 아웃소싱하는 것을 선택하고 있습니다. 현재 80개 이상의 업체가 450개 이상의 연구 및 치료용 원료를 공급하고 있습니다. 또한 T세포, 줄기세포, 수지상세포, NK세포 등 다양한 인간 세포에 사용하기 위한 소모품을 생산할 수 있는 GMP 인증 시설을 보유하고 있다고 주장하는 업체도 있습니다.
세포치료의 환경이 계속 진화하는 가운데, 업계내 기술 혁신과 협력이 급증하면서 환자 치료를 변화시키고 재생의료의 지평을 넓힐 수 있는 새로운 치료 옵션의 길이 열릴 것으로 예상됩니다.
세계의 세포치료용 배지 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 세포치료 유형별, 사업 규모별, 최종사용자 유형별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
목차
제1장 서문
제2장 개요
제3장 서론
제4장 시장 구도
제5장 기업 경쟁력 분석
제6장 주요 업계의 브랜드 포지셔닝
제7장 기업 개요
장의 개요
STEMCELL Technologies
Miltenyi Biotec
Thermo Fisher Scientific
Bio-Techne
Irvine Scientific
Lonza
Sartorius
BD Biosciences
Corning
CellGenix
제8장 최근 동향과 구상
제9장 세포치료 소모품 프로바이더의 적절한 파트너 분석
제10장 루트 분석 가격 전략
제11장 수요 분석
제12장 시장 예측과 기회 분석
제13장 향후 동향과 향후 성장 기회
제14장 결론
제15장 인터뷰 기록
제16장 부록 I : 표 형식 데이터
제17장 부록 II : 기업 및 조직 리스트
KSA
영문 목차
영문목차
CELL THERAPY MEDIA MARKET: OVERVIEW
As per Roots Analysis, the global cell therapy media market is estimated to grow from USD 1.1 billion in the current year to USD 4.4 billion by 2035, at a CAGR of ~12% during the forecast period, till 2035.
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Product
Culture Media, Kits
Cell Culture Reagents
Extracellular Matrices
Type of Cell Therapy
T-Cell Therapy
Stem Cell Therapy
Dendritic Cell Therapy
NK Cell Therapy
Scale of Operation
Clinical
Commercial
Type of End User
Industry
Non-Industry
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
CELL THERAPY MEDIA MARKET: GROWTH AND TRENDS
Driven by numerous advancements and the proven success of FDA approved cell therapies for the treatment of oncological disorders, rare diseases, and chronic diseases, this therapeutic modality has garnered considerable attention of players engaged in the healthcare industry. It is worth highlighting that, since 2019, more than 1,000 clinical trials focused on cell therapies have been initiated. Additionally, over 35 cell and gene therapies have been commercialized, across various geographical locations. Notable examples of recently approved cell therapies include Breyanzi(R), Carvykti(TM) and Abecma(R).
In recent years, regulatory stringency has increased for the production of cell therapy. In order to address the regulatory challenges linked to the production of cell therapy consumables, over 90% of cell therapy developers choose to outsource culture media, kits, reagents and extracellular matrices to suppliers who possess the necessary expertise to deliver high-quality raw materials. At present, more than 80 players are offering more than 450 research and / or therapeutic grade raw materials. In addition, some companies claim to have GMP certified facilities for the production of consumables, which are intended to be used for a range of human cells, including T-cells, stem cells, dendritic cells and NK cells.
As the landscape of cell therapy continues to evolve, we anticipate a surge in innovation and collaboration within the industry, paving the way for new therapeutic options that could transform patient care and expand the horizons of regenerative medicine.
CELL THERAPY MEDIA MARKET: KEY INSIGHTS
The report delves into the current state of the cell therapy media market and identifies potential growth opportunities within the industry. Some key findings from the report include:
1. Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes.
2. The market features the presence of over 80 firms across the globe; the majority of these stakeholders are emerging players based in North America.
3. A larger proportion of the kits available in the cell therapy domain comprises different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions.
4. Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml.
5. Predominantly, the cell therapy reagents are intended to be used at the discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation.
6. The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation.
7. In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios.
8. Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities.
9. We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings.
10. Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies.
11. Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process.
12. In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy consumables; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies.
13. A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy consumables market at an annualized rate of 12%.
CELL THERAPY MEDIA MARKET: KEY SEGMENTS
Extracellular Matrices is the Fastest Growing Segment in the Cell Therapy Media Market
Based on the type of product, the market is segmented into culture media, kits, cell culture reagents and extracellular matrices. It is worth highlighting that majority of the current cell therapy media market is captured by culture media.
T-Cell Therapy is Likely to Dominate the Cell Therapy Media Market During the Forecast Period
Based on the type of cell therapy, the market is segmented into T-Cell therapy, stem cell therapy, dendritic cell therapy and NK cell therapy. It is worth highlighting that the cell therapy consumables market for NK cell therapies is likely to grow at a relatively higher CAGR, during the forecast period. This can be attributed to the fact that currently, more than 75 NK cell therapy focused clinical studies are being evaluated for a myriad of disease indications. In the coming years, this number is anticipated to increase further, and this is likely to boost the market opportunity for such therapies.
By Scale of Operation, Commercial Scale is Likely to Dominate the Cell Therapy Media Market During the Forecast Period
Based on the scale of operation, the market is segmented into clinical and commercial scales. It is worth highlighting that the commercial scale cell therapy media market is likely to drive the market in the near future.
Industry Players Segment Accounts for the Largest Share of the Cell Therapy Media Market
Based on the type of end user, the market is segmented into industry and non-industry. It is worth highlighting that the cell therapy media market for industry players is likely to drive the market in the near future. This can be attributed to the fact that the industry players contribute significantly to the overall commercial market as majority of the approved therapies have been developed by such players.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. It is worth highlighting that, over the years, the market in Latin America is expected to grow at a higher CAGR.
Example Players in the Cell Therapy Media Market
BD Biosciences
Bio-Techne
CellGenix
Corning
Irvine Scientific (Acquired by FUJIFILM)
Lonza
Miltenyi Biotech
Sartorius
STEMCELL Technologies
Thermo Fisher Scientific
Primary Research Overview
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
Vice President of Business Development - Cell Therapy, Akadeum Life Sciences
The report features an in-depth analysis of the cell therapy media market, focusing on key market segments, including type of product, type of cell therapy, scale of operation, type of end user and key geographical regions.
A comprehensive evaluation of companies offering cell culture consumables and cell culture media, considering various parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of product (kits, media, reagents and extracellular matrices), number and location of consumable facilities, accreditations received, type of end-user (industry and non-industry), cell culture media compatibility (serum free media, xeno free media and both), type of cell therapy (T-cell therapies, stem cell therapies, NK cell therapies, dendritic cell therapies and others), type of function (cell proliferation, cell expansion, cell differentiation, cell activation, cell isolation, cell attachment), kit components (supplements / reagents, growth / induction medium, expansion medium, differentiation medium and others), type of ECM coating (laminin, fibronectin, vitronectin, basement membrane extract and others), type of formulation (powder, liquid, pre-coated cultureware), shelf life (6-12 months, 13-18 months, 19-24 months and 25-36 months), scale of operation (discovery, preclinical, clinical and commercial), application area (research use and therapeutic use), storage temperature (refrigerated, frozen, ultra-low and room temperature), as well as volume of media, reagents and extracellular matrices.
A comprehensive competitive analysis of companies operating in the cell culture consumable and cell culture media market, examining factors such as supplier strength, portfolio strength and number of products offered.
A detailed brand positioning analysis of prominent industry players (shortlisted on the basis of strength of service portfolio), highlighting the current perceptions regarding their proprietary brands across different consumable classes.
In-depth profiles of key industry players in cell therapy consumables and cell culture media market, focusing on company overviews, product portfolio, consumable facilities, recent developments and an informed future outlook.
An analysis of recent developments within the cell culture consumables and cell culture media market, since 2016, covering partnerships and collaborations, mergers and acquisitions, and expansion initiatives.
A detailed evaluation of over 250 cell therapy developers that are most likely to collaborate with cell culture consumables and cell culture media providers. This analysis considers various relevant parameters, including developer strength (which takes into account a company's size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development), and availability of other cell therapy capabilities.
A proprietary Roots Analysis competitive pricing framework, which analyzes the competitive position of various companies engaged in cell culture consumables and cell culture media market, by taking into consideration the prices and features of their consumable offerings (such as media and extracellular matrices). In addition, it presents an equation devised to calculate the likely price of cell therapy consumables based upon their characteristics.
Informed estimates of the annual demand for cell culture consumables and cell culture media (in terms of volume of media required for total number of cells), based on scale of operation and key geographical regions.
A comprehensive analysis of emerging trends and future growth prospects in the cell culture consumables and media market. It includes details related to the significance of automation in cell therapy manufacturing processes and the benefits of single use technologies for the production of cell therapies.
KEY QUESTIONS ANSWERED IN THIS REPORT
What are the factors driving the cell therapy consumables market?
How many players are engaged in offering cell culture media for manufacturing cell therapies?
How many players are engaged in offering kits for manufacturing cell therapies?
How many media products are available in the market for culturing cell therapies?
What are the partnership and collaboration trends observed in the cell therapy consumables domain?
Which geographical segment captures the largest market share in the current cell therapy consumables market?
Which type of product contributes to the largest share of the cell therapy consumables market?
REASONS TO BUY THIS REPORT
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
10% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older
TABLE OF CONTENTS
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Therapies
3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
3.7. Types of Cell Therapy Consumables
3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
3.9. Future Perspectives
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Cell Therapy Kit Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Kit Manufacturing Facilities
4.2.5. Analysis by Certifications / Accreditations Received
4.2.6. Analysis by Type of End-User
4.2.7. Analysis by Type of Cell Therapy
4.2.8. Analysis by Type of Function
4.2.9. Analysis by Kit Components
4.2.10. Analysis by Storage Temperature
4.2.11. Analysis by Scale of Operation
4.2.12. Analysis by Application Area
4.2.13. Analysis by Application Area and Geography
4.3. List of Cell Therapy Media Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Location of Media Manufacturing Facilities
4.3.5. Analysis by Certifications / Accreditations Received
4.3.6. Analysis by Type of End-User
4.3.7. Analysis by Type of Cell Therapy
4.3.8. Analysis by Media Compatibility
4.3.9. Analysis by Type of Function
4.3.10. Analysis by Storage Temperature
4.3.11. Analysis by Volume of Media
4.3.12. Analysis by Scale of Operation
4.3.13. Analysis by Application Area
4.3.14. Analysis by Application Area and Geography
4.4. List of Cell Therapy Reagent Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Location of Reagent Manufacturing Facilities
4.4.5. Analysis by Certifications / Accreditations Received
4.4.6. Analysis by Type of End-User
4.4.7. Analysis by Type of Cell Therapy
4.4.8. Analysis by Type of Function
4.4.9. Analysis by Storage Temperature
4.4.10. Analysis by Volume of Reagent
4.4.11. Analysis by Scale of Operation
4.4.12. Analysis by Application Area
4.4.13. Analysis by Application Area and Geography
4.5. List of Cell Therapy Extracellular Matrix Providers
4.5.1. Analysis by Year of Establishment
4.5.2. Analysis by Company Size
4.5.3. Analysis by Location of Headquarters
4.5.4. Analysis by Location of Extracellular Matrix Manufacturing Facilities
4.5.5. Analysis by Certifications / Accreditations Received
4.5.6. Analysis by Type of End-User
4.5.7. Analysis by Type of Stem Cell Therapy
4.5.8. Analysis by Type of Function
4.5.9. Analysis by Type of ECM Coating
4.5.10. Analysis by Type of Formulation
4.5.11. Analysis by Shelf Life
4.5.12. Analysis by Storage Temperature
4.5.13. Analysis by Volume of Extracellular Matrix
4.5.14. Analysis by Scale of Operation
4.5.15. Analysis by Application Area
4.5.16. Analysis by Application Area and Geography
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Cell Therapy Consumable Providers: Company Competitiveness Analysis
5.5. Cell Therapy Kits Providers
5.6. Cell Therapy Media Providers
5.6.1. Cell Therapy Media Providers based in North America
5.6.2. Cell Therapy Media Providers based in Europe
5.6.3. Cell Therapy Media Providers based in Asia-Pacific
5.7. Cell Therapy Reagent Providers
5.8. Cell Therapy Extracellular Matrix Providers
6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Brand Positioning: STEMCELL Technologies
6.4. Brand Positioning: Miltenyi Biotec
6.5. Brand Positioning: Thermo Fisher Scientific
6.6. Brand Positioning: Takara Bio
6.7. Brand Positioning: GeminiBio
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Miltenyi Biotec
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Thermo Fisher Scientific
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. Bio-Techne
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Irvine Scientific
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
7.7. Lonza
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook
7.8. Sartorius
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook
7.9. BD Biosciences
7.9.1. Company Overview
7.9.2. Product Portfolio
7.9.3. Recent Developments and Future Outlook
7.10. Corning
7.10.1. Company Overview
7.10.2. Product Portfolio
7.10.3. Recent Developments and Future Outlook
7.11. CellGenix
7.11.1. Company Overview
7.11.2. Product Portfolio
7.11.3. Recent Developments and Future Outlook
8. RECENT DEVELOPMENTS AND INITIATIVES
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Consumables: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Cell Therapy
8.3.7. Analysis by Type of Product and Type of Cell Therapy
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Region
8.3.9.1. Intercontinental and Intracontinental Agreements
8.3.9.2. Local and International Agreements
8.4. Cell Therapy Consumables: Mergers and Acquisitions
8.4.1. Cumulative Year-wise Trend of Mergers and Acquisitions
8.4.2. Analysis by Type of Agreement
8.4.3. Analysis by Key Value Drivers
8.4.4. Analysis by Year of Acquisition and Key Value Drivers
8.5. Cell Therapy Consumables: Recent Expansions
8.5.1. Analysis by Year of Expansion
8.5.2. Analysis by Type of Expansion
8.5.3. Analysis by Year and Type of Expansion
8.5.4. Analysis by Type of Product
8.5.5. Analysis by Type of Expansion and Type of Product
8.5.6. Analysis by Area of Expansion
8.5.7. Most Active Players: Analysis by Number of Expansions
8.5.8. Analysis by Region
8.5.8.1. Analysis by Location of Facility (Continent-wise)
8.5.8.2. Analysis by Location of Facility (Country-wise)
8.5.9. Analysis by Type of Expansion and Location of Facility
9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
9.4.1. Likely Partners for Dendritic Cell Therapy Consumable Providers
9.4.2. Likely Partners for NK Cell Therapy Consumable Providers
9.4.3. Likely Partners for Stem Cell Therapy Consumable Providers
9.4.4. Likely Partners for T-Cell Therapy Consumable Providers
10. ROOTS ANALYSIS PRICING STRATEGY
10.1. Chapter Overview
10.2. Roots Analysis Framework
10.2.1. Theoretical Framework and Price Evaluation Hypothesis for Cell Therapy Media
10.2.1.1. Methodology
10.2.1.2. Results and Interpretation
10.2.1.2.1. Cell Therapy Media Price Evaluation Matrix: Information on Volume of Media
10.2.1.2.2. Cell Therapy Media Price Evaluation Matrix: Information on Media Compatibility
10.2.1.2.3. Cell Therapy Media Price Evaluation Matrix: Information on Type of Product Manufacturing Practices
10.2.1.2.4. Cell Therapy Media Price Evaluation Matrix: Information on Application Area
10.2.1.2.5. Cell Therapy Media Price Evaluation Matrix: Information on Storage Temperature
10.2.1.2.6. Cell Therapy Media Price Evaluation Matrix: Information on Type of Cell Therapy
10.2.1.2.7. Cell Therapy Media Price Evaluation Matrix: Information on Type of Function
10.2.2. Theoretical Framework and Price Evaluation Hypothesis of Cell Therapy Extracellular Matrices
10.2.2.1. Methodology
10.2.2.2. Results and Interpretation
10.2.2.2.1. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of ECM Coating
10.2.2.2.2. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Formulation
10.2.2.2.3. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Volume of Extracellular Matrices
10.2.2.2.4. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Storage Temperature
10.2.2.2.5. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Shelf Life
10.2.2.2.6. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Stem Cell Therapy
10.2.2.2.7. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Function
11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Cell Therapy Consumables
11.3.1. Global Demand for Cell Therapy Consumables for Planar Processes
11.3.2. Global Demand for Cell Therapy Consumables for Suspension Processes
11.4. Analysis by Scale of Operation
11.5. Analysis by Geography
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Therapy Consumables Market, till 2035
12.4. Cell Therapy Consumables Market: Analysis by Type of Product
12.4.1. Cell Therapy Consumables Market for Extracellular Matrices, till 2035
12.4.2. Cell Therapy Consumables Market for Kits, till 2035
12.4.3. Cell Therapy Consumables Market for Media, till 2035
12.4.4. Cell Therapy Consumables Market for Reagents, till 2035
12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
12.5.1. Cell Therapy Consumables Market for Dendritic Cell Therapies, till 2035
12.5.2. Cell Therapy Consumables Market for NK Cell Therapies, till 2035
12.5.3. Cell Therapy Consumables Market for Stem Cell Therapies, till 2035
12.5.4. Cell Therapy Consumables Market for T-Cell Therapies, till 2035
12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
12.6.1. Cell Therapy Consumables Market for Clinical Operations, till 2035
12.6.2. Cell Therapy Consumables Market for Commercial Operations, till 2035
12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
12.7.1. Cell Therapy Consumables Market for Industry Players, till 2035
12.7.2. Cell Therapy Consumables Market for Non-Industry Players, till 2035
12.8. Cell Therapy Consumables Market: Analysis by Geography
12.8.1. Cell Therapy Consumables Market in North America, till 2035
12.8.1.1. Cell Therapy Consumables Market in the US, till 2035
12.8.1.2. Cell Therapy Consumables Market in Canada, till 2035
12.8.1.3. Cell Therapy Consumables Market in Rest of North America, till 2035
12.8.2. Cell Therapy Consumables Market in Europe, till 2035
12.8.2.1. Cell Therapy Consumables Market in Spain, till 2035
12.8.2.2. Cell Therapy Consumables Market in France, till 2035
12.8.2.3. Cell Therapy Consumables Market in Germany, till 2035
12.8.2.4. Cell Therapy Consumables Market in Italy, till 2035
12.8.2.5. Cell Therapy Consumables Market in the Netherlands, till 2035
12.8.2.6. Cell Therapy Consumables Market in the UK, till 2035
12.8.2.7. Cell Therapy Consumables Market in Rest of Europe, till 2035
12.8.3. Cell Therapy Consumables Market in Asia-Pacific, till 2035
12.8.3.1. Cell Therapy Consumables Market in China, till 2035
12.8.3.2. Cell Therapy Consumables Market in Korea, till 2035
12.8.3.3. Cell Therapy Consumables Market in Rest of Asia-Pacific, till 2035
12.8.4. Cell Therapy Consumables Market in Middle East and North Africa, till 2035
12.8.5. Cell Therapy Consumables Market in Latin America, till 2035
13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Emerging Trends Related to Cell Culture Media
13.3. Automation of Cell Therapy Manufacturing Processes
13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing
14. CONCLUDING REMARKS
15. INTERVIEW TRANSCRIPTS
15.1. Chapter Overview
15.2. Akadeum Life Sciences
15.2.1. Interview Transcript: Michael Maloney, Vice President of Business Development - Cell Therapy
